Tag: MOLNUPIRAVIR PILL

The World Health Organisation (WHO) has updated the guidelines for the treatment of COVID-19 patients, as it allows the conditional use of Molnupiravir, an anti-viral pill. This is the first anti-viral oral pill that is included in the treatment of the disease. Along with this, WHO has recommended active monitoring as the drug is new and safety data needs more detailed inputs. Due to these shortcomings, WHO recommends using it in only non-severe and high-risk hospitalization cases only.  This will include non-vaccinated people, old age people with chronic diseases and immuno-deficiency disorders. Consuming Molnupiravir: Do And Dont's Molnupiravir is an oral anti-viral pill by the US pharmaceutical company, Merck. Some people also refer to this pill as 'Merck Pill'.  A patient need...